Trial of Psilocybin versus Escitalopram for Depression
Background Psilocybin may have antidepressant properties, but direct comparisons between psilocybin and established treatments for depression are lacking. Methods In a phase 2, double-blind,
Background Psilocybin may have antidepressant properties, but direct comparisons between psilocybin and established treatments for depression are lacking. Methods In a phase 2, double-blind,
Background Psilocybin is being studied for use in treatment-resistant depression. Methods In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant depression
©2025 Unlimited Sciences. All rights reserved.
We hate pop-ups as much as you do, but if you want to stay up to date about the latest news in the psychedelic space and learn about our ground-breaking psychedelic research, please consider signing up for our newsletter below.